DTR — Diagnostear Technologies Cashflow Statement
0.000.00%
Last trade - 00:00- CA$19.40m
- CA$17.91m
Annual cashflow statement for Diagnostear Technologies, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -1.19 | -1.15 | -16 |
| Non-Cash Items | 0.459 | 0.12 | 14.5 |
| Other Non-Cash Items | |||
| Cash from Operating Activities | -0.728 | -1.03 | -1.5 |
| Capital Expenditures | -0.028 | -0.515 | 0 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | -0.01 | 0 | 0.178 |
| Sale of Fixed Assets | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -0.038 | -0.515 | 0.178 |
| Financing Cash Flow Items | — | — | 3.31 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 0.373 | 1.73 | 3.64 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -0.421 | 0.177 | 2.2 |